Syrup salbutamol dosage for 5 month old child
Reading File
Finding Sources
Finding Sources
Finding Sources
Reading File
The textbook source found clearly states PO (oral/syrup) salbutamol is NOT recommended in the management of asthma/wheeze in children. Here is a comprehensive answer based on that, supplemented by established clinical guidance:
Salbutamol Syrup — 5-Month-Old Infant
Key Clinical Point
Oral (syrup) salbutamol is not recommended for infants or children in current evidence-based guidelines. Tintinalli's Emergency Medicine explicitly states under pediatric asthma dosages:
"PO: Not recommended" — Tintinalli's Emergency Medicine, p. 847
This applies to all pediatric age groups, including infants.
Why Oral Salbutamol is Not Preferred
- Inhaled salbutamol (via MDI + spacer/mask or nebulization) delivers the drug directly to the airways with a much lower dose and fewer systemic side effects
- Oral formulations have slower onset, poor lung bioavailability, and higher rates of systemic adverse effects (tachycardia, tremor, hypokalemia)
- In infants under 1 year, bronchodilator response is often poor regardless of route due to immature airway smooth muscle
Preferred Route for a 5-Month-Old
| Route | Dosage |
|---|---|
| MDI + spacer with infant mask | 2 puffs (100 mcg/puff) per dose |
| Nebulization (5 mg/mL solution) | < 10 kg: 1.25 mg per dose (0.25 mL of 5 mg/mL solution) |
For a 5-month-old (typically ~6–8 kg), the nebulized dose is 1.25 mg per treatment.
If Oral Salbutamol Has Been Prescribed
In some lower-resource settings, oral salbutamol syrup (2 mg/5 mL) is still prescribed. The general off-label dosing used is:
- 0.1–0.15 mg/kg/dose, 3–4 times daily
- For a ~7 kg infant: approximately 0.7–1 mg per dose (roughly 1.75–2.5 mL of 2 mg/5 mL syrup)
- Maximum: 2 mg per dose in infants
⚠️ This should only be given under a doctor's direct instruction. Oral salbutamol is not guideline-recommended and carries cardiac side effects in infants.
Bottom Line
A 5-month-old with wheeze or breathing difficulty should be assessed by a physician. The preferred treatment is inhaled salbutamol via nebulizer or spacer with mask, not syrup. If syrup has already been prescribed, follow the prescribing clinician's specific instructions.
This is a shared conversation. Sign in to Orris to start your own chat.